These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 291506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients.
    Ong YL, Deore R, El-Agnaf M.
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e151-7. PubMed ID: 19016918
    [Abstract] [Full Text] [Related]

  • 3. [Must we always treat hyperkalaemia?].
    Basile C, Manobianca G, Bruno A, Tamma F.
    G Ital Nefrol; 2013 Feb; 30(1):. PubMed ID: 23832444
    [Abstract] [Full Text] [Related]

  • 4. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B, Meuthen I.
    Dtsch Med Wochenschr; 1986 Feb 28; 111(9):329-32. PubMed ID: 3948731
    [Abstract] [Full Text] [Related]

  • 5. Pseudohyperkalaemia - a cause of diagnostic confusion.
    Parker NE, Jacobs P.
    S Afr Med J; 1981 Dec 19; 60(25):973-4. PubMed ID: 7330742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS, Woods AI, Schattner MA, Lazzari MA.
    Medicina (B Aires); 1981 Dec 19; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pathogenetic mechanism of the changing cell picture in myeloproliferative syndromes (author's transl)].
    Bakalos D, Pararas M, Pathouli C, Tsikrikas T.
    MMW Munch Med Wochenschr; 1974 Feb 22; 116(8):369-72. PubMed ID: 4208094
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Meningeal leukemia during blast crisis in a chronic myeloproliferative syndrome].
    Gabryś K, Kuliczkowski K.
    Wiad Lek; 1981 Feb 01; 34(3):245-9. PubMed ID: 6942592
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
    Leoncini G, Maresca M, Balestrero F, Benatti U, Armani U, Piana A.
    Cell Biochem Funct; 1984 Jan 01; 2(1):23-5. PubMed ID: 6467512
    [Abstract] [Full Text] [Related]

  • 16. Thrombocytosis and hyperkalemia revisited.
    Fort JA.
    Am J Pediatr Hematol Oncol; 1989 Jan 01; 11(3):334-6. PubMed ID: 2782564
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Report on familial paroxysmal hypokalaemic paralysis in relation to postoperative intensive care (author's transl)].
    Feurstein V.
    Anaesthesist; 1980 Nov 01; 29(11):632-4. PubMed ID: 7457804
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.